Sotera Health Company (SHC) financial statements and ratios from SEC XBRL: revenue $1.2B (TTM), net margin 6.7%, revenue growth 9.2% YoY, P/E 34.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.16B |
| Revenue (TTM) | $1.2B |
| Net Margin | 6.7% |
| Operating Margin (TTM) | 21.7% |
| Net Debt / EBITDA | 4.9 |
| Revenue Growth (YoY) | 9.2% |
| EPS Growth (YoY) | 533.3% |
| FCF Growth (YoY) | 60.6% |
| P/E Ratio | 34.1 |
| EV / EBITDA | 20.0 |
| Price / Book | 8.36 |
| Price / Sales | 4.58 |
| FCF Yield | 2.0% |
| Altman Z-Score | 1.66 (distress) |
| Piotroski F-Score | 6/9 |
| Piotroski checks passed | 6 of 9 |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
SHC overview · SHC earnings · SHC KPIs · SHC documents · SHC ownership · SHC peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.